Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1940 1
1958 2
1960 5
1962 5
1963 6
1964 3
1965 5
1966 2
1967 1
1968 1
1969 3
1970 7
1971 5
1972 8
1973 5
1974 6
1975 14
1976 10
1977 10
1978 9
1979 8
1980 14
1981 11
1982 18
1983 21
1984 16
1985 12
1986 29
1987 24
1988 20
1989 14
1990 20
1991 33
1992 36
1993 23
1994 24
1995 34
1996 24
1997 34
1998 53
1999 57
2000 62
2001 61
2002 66
2003 88
2004 104
2005 99
2006 150
2007 184
2008 184
2009 199
2010 227
2011 253
2012 334
2013 358
2014 341
2015 385
2016 470
2017 493
2018 515
2019 560
2020 643
2021 727
2022 797
2023 12
Text availability
Article attribute
Article type
Publication date

Search Results

7,170 results
Results by year
Filters applied: . Clear all
Page 1
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
Shi R, Wang X, Wu Y, Xu B, Zhao T, Trapp C, Wang X, Unger K, Zhou C, Lu S, Buchner A, Schulz GB, Cao F, Belka C, Su C, Li M, Shu Y. Shi R, et al. Among authors: su c. Theranostics. 2022 May 16;12(9):4181-4199. doi: 10.7150/thno.73235. eCollection 2022. Theranostics. 2022. PMID: 35673559 Free PMC article.
Reply to Lai and Wei.
Su CP, Chan KA, Huang CT, Fang CT. Su CP, et al. Clin Infect Dis. 2022 Sep 29;75(6):1113. doi: 10.1093/cid/ciac336. Clin Infect Dis. 2022. PMID: 35475914 No abstract available.
Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant.
Ma W, Yang J, Fu H, Su C, Yu C, Wang Q, de Vasconcelos ATR, Bazykin GA, Bao Y, Li M. Ma W, et al. Among authors: su c. Genomics Proteomics Bioinformatics. 2022 Feb;20(1):60-69. doi: 10.1016/j.gpb.2022.01.001. Epub 2022 Jan 13. Genomics Proteomics Bioinformatics. 2022. PMID: 35033679 Free PMC article.
Emerging insights to lung cancer drug resistance.
Su C. Su C. Cancer Drug Resist. 2022 Jun 21;5(3):534-540. doi: 10.20517/cdr.2022.61. eCollection 2022. Cancer Drug Resist. 2022. PMID: 36176761 Free PMC article.
Immunotherapy resistance of lung cancer.
Yu X, Han C, Su C. Yu X, et al. Among authors: su c. Cancer Drug Resist. 2022 Feb 8;5(1):114-128. doi: 10.20517/cdr.2021.101. eCollection 2022. Cancer Drug Resist. 2022. PMID: 35582531 Free PMC article.
4D-printed pH sensing claw.
Wu CY, Chen JR, Su CK. Wu CY, et al. Among authors: su ck. Anal Chim Acta. 2022 Apr 29;1204:339733. doi: 10.1016/j.aca.2022.339733. Epub 2022 Mar 17. Anal Chim Acta. 2022. PMID: 35397904
Ligand-receptor promiscuity enables cellular addressing.
Su CJ, Murugan A, Linton JM, Yeluri A, Bois J, Klumpe H, Langley MA, Antebi YE, Elowitz MB. Su CJ, et al. Cell Syst. 2022 May 18;13(5):408-425.e12. doi: 10.1016/j.cels.2022.03.001. Epub 2022 Apr 13. Cell Syst. 2022. PMID: 35421362 Free article.
7,170 results